Vice-versa, the reduction of periodontal inflammation through plaque control, systemic antibiotics, scaling, and root planning seems to decrease CRP levels in patients suffering from MetS, reducing the risk of CVD[63]. This evidence concerns the gene CRP and metabolic syndrome.